symbol-MEDEZE

MEDEZE Medeze Group Public Company Limited

MEDEZE
Medeze Group Public Company Limited
6.10
-0.05 (-0.81%)
High6.20
Low6.10
Total Vol42,000
Total Val(K)256.00
Description
The company provides services in the analysis, isolation, cultivation, and storage of stem cells, as well as NK cells potency testing.

Overview


  • SymbolMEDEZE
  • Market Cap (M.Bath)6,568.20
  • IPO Date15 Oct 2024
  • IPO Price9.00 @Par Value 0.50 Baht
  • CEOMrs. WATCHAREE TINTANI
  • Employees-
  • IndustrySERVICE
  • SectorHELTH
  • IndexsSET
  • SET ESG Ratings-

สรุปภาพรวมตลาด

Medeze Group Public Company Limited
Websitehttps://www.medezegroup.com
Address28/9 Village No. 8, Phutthamonthon Sai 4 Road, Krathum Lom Subdistrict, Sam Phran District Nakorn Phathom 73220
Telephone0-9159-9999-99
Fax0-2009-8889

Detail of Security

MarketSET
First Trade Date15 Oct 2024
IndustrySERVICE
SectorHELTH
Foreign Limit (%)49.00 (Date 29 Apr 2026)
Foreign Ownership Limit Remaining (shares)514,301,500
Free Float (%)25.56
Par Value0.50
ISIN Number
Local : THC430010007
Foreign : THC430010015
NVDR : THC430010R18
Dividend PolicyThe Company has a policy to pay dividends to shareholders of no less than 30% of the net profit from the separate financial statements, after the deduction of corporate income tax and all types of reserves as required by law and the Company`s regulations. This also includes reserving additional excess cash from business operations to ensure that the Company maintains sufficient total assets, thereby preventing it from being classified as an investment company according to the regulations of the Securities and Exchange Commission (SEC) and other relevant authorities. However, such dividend payments may be subject to change, depending on the Company`s performance, financial liquidity, the need for working capital to manage the business, and future expansion plans of the Company and its subsidiaries, as deemed appropriate by the Board of Directors. Annual dividend payments must be approved by the shareholders` meeting, except for interim dividends, which the Board of Directors may occasionally approve if it is determined that the Company has sufficient profits to do so without affecting the Company`s operations. The interim dividend payments must be reported to the shareholders at the next meeting. According to Section 115 of the Public Limited Companies Act B.E. 2535 (1992) (including any amendments), dividend payments from any source other than profits are prohibited. Therefore, if the Company has accumulated losses, it is prohibited from paying dividends
Fiscal End31 Dec 2026
The person supervising accountingMr. Anurak Prommongkon (Start Date 26 Jan 2021)
The person taking the highest responsibility in finance and accountingMiss Anchisa Lekphet (Start Date 1 Jun 2025)
Capital Detail
Common Stock
Authorized Capital534,000,000
Paid-up Capital534,000,000
Preferred Shares
Authorized Capital-
Paid-up Capital-
Shares Detail
Common Stock
Listed Shares1,068,000,000
Paid-up Stock1,068,000,000Voting Right Ratio 1:1
Treasury Stock - : - - : -
Voting Stock minus Treasury Stock 31 Mar 2026 : 1,068,000,000 30 Apr 2026 : 1,068,000,000
Preferred Shares
Listed Shares-
Paid-up Stock-Voting Right Ratio -
Treasury Stock - : - - : -
Voting Stock minus Treasury Stock - : - - : -

Key Issues

Upcoming Event

Relate Stock Sectors

Check out other big names from the same Sectors MEDEZE

symbol-https://s3.efinancethai.com/symbols-logo/MEDEZE.pngMEDEZE
efin Focus Metrics
Quarter 4/2025
Z-Score
8.35
10.00
0.79
Monitor C-Score
0.00
0.00
0.00
ICR
11.40
1,327.07
-1.50
DSCR
5.57
131.39
0.00
EV/EBITDA
21.15
11.45
448,199.17
FCF Yield
6.85
12.46
22.29
FCF/Net Income
2.37
2.23
0.00
Net Debt/EBITDA
-4.30
-0.49
0.00
ROIC
58.26
25.55
-2.18
Valuation Metrics
Last Price
6.10
16.20
1.73
P/E
34.53
17.87
0.00
P/BV
2.33
2.50
0.74
Dividend Yield
2.52
2.14
0.59
Financial Strength
D/E
0.19
0.20
0.61
Current Ratio
13.38
3.82
0.56
Net Profit Margin
24.02
15.26
-7.42
ROE/ROA
0.93
0.96
2.79
Growth Metrics
Revenue Growth YoY
-20.11
10.00
13.61
Revenue Growth 3Y
0.00
26.81
17.01
Revenue Growth 3Y CAGR
0.00
8.24
5.38
Revenue per Share
0.00
0.00
0.00
EPS Growth
-63.02
5.18
-71.70
EBITDA Growth
1,027.26
13.55
0.93
5Y CAGR Total Return
0.00
11.31
-18.76
Market Cap (M.Bath)
6,781.80
14,703.81
6,474.57
Average Volume
6,918.08
35,578.23
2,519.90

efin Focus Metrics

Quarter 4/2025
Z-Score
Monitor C-Score
ICR
DSCR
EV/EBITDA
FCF Yield
FCF/Net Income
Net Debt/EBITDA
ROIC
Z-Score
xxx
xxx
xxx
Monitor C-Score
xxx
xxx
xxx
ICR
xxx
xxx
xxx
DSCR
xxx
xxx
xxx
EV/EBITDA
xxx
xxx
xxx
FCF Yield
xxx
xxx
xxx
FCF/Net Income
xxx
xxx
xxx
Net Debt/EBITDA
xxx
xxx
xxx
ROIC
xxx
xxx
xxx

Valuation Metrics

Last Price
6.10
16.20
1.73
P/E
34.53
17.87
0.00
P/BV
2.33
2.50
0.74
Dividend Yield
2.52
2.14
0.59

Financial Strength

D/E
0.19
0.20
0.61
Current Ratio
13.38
3.82
0.56
Net Profit Margin
24.02
15.26
-7.42
ROE/ROA
0.93
0.96
2.79

Growth Metrics

Revenue Growth YoY
-20.11
10.00
13.61
Revenue Growth 3Y
0.00
26.81
17.01
Revenue Growth 3Y CAGR
0.00
8.24
5.38
Revenue per Share
0.00
0.00
0.00
EPS Growth
-63.02
5.18
-71.70
EBITDA Growth
1,027.26
13.55
0.93
5Y CAGR Total Return
0.00
11.31
-18.76
Market Cap (M.Bath)
6,781.80
14,703.81
6,474.57
Average Volume
6,918.08
35,578.23
2,519.90
Note
  • Calculated using adjusted prices.
  • Data is shown and calculated based on consolidated financial statements, presented as year-to-date quarterly figures. (If consolidated statements are unavailable, company-only statements are used.)
  • Financial data is updated quarterly within 7 business days after new statements are released.
  • Financial statement data reflects what listed companies submit for each period. Users should review the full financial statements for details, as some companies may revise comparative figures in the latest full version.
  • The list of companies included in the SETESG Index is announced together with other indices, based on the latest SET ESG Ratings results. Source: www.set.or.th (Copyright @ The Stock Exchange of Thailand).